ARCHIVES

About Face; NCI To Keep Preclinical AIDS Drug Development

This article is from The Cancer Letter archive.

Vol. 12 No. 48 | December 12, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Declares Taxol Orphan Drug For KS; Can IVAX Break Bristol’s Exclusivity?

August 15, 1997

Cancer Clinical Trials Approved By NCI Last Month Are Listed

November 29, 2002

CMS Removes Obstacles for Contractors to Deny EPO Coverage for Cancer Anemia.

March 9, 2007

NCI Buys Building For PDQ, ICRDB With Donated Money

December 10, 1982

In Brief: Online Genetics Glossary; ORI Misconduct Finding

February 5, 1999

Senate Report Calls on NCI To Expand Research in Survivorship, CAM, GYN Cancers, And Fund Five Pancreatic SPOREs

August 2, 2002